Meanwhile, LARS promoted tumor growth and raised the expression of LA (the product of glycolysis) and that of HK2, GLUT1, and HIF-1α, the key enzymes in glycolysis, which were reversed upon 2-DG treatment. Here, SLC2A1 is linked to neoplasm.